Her primary scientific interests are in Pharmacology, Dopamine transporter, Dopamine, Dopamine receptor D3 and Benztropine. Her studies deal with areas such as Antagonist, Addiction and Reuptake inhibitor as well as Pharmacology. Her Dopamine transporter study integrates concerns from other disciplines, such as In vitro and Modafinil.
Her research links Receptor with Dopamine. Her Dopamine receptor D3 research incorporates themes from Methamphetamine, Brain stimulation reward, Partial agonist, Neurochemical and Carboxamide. The study incorporates disciplines such as Dopamine transport, Stimulant, In vivo and Tropane in addition to Benztropine.
Pharmacology, Dopamine, Dopamine transporter, Dopamine receptor D3 and Stereochemistry are her primary areas of study. Her work in Pharmacology addresses subjects such as Addiction, which are connected to disciplines such as Substance abuse. Nucleus accumbens and Microdialysis are the primary areas of interest in her Dopamine study.
Amy Hauck Newman has included themes like Benztropine, Cell biology and Tropane in her Dopamine transporter study. Her Dopamine receptor D3 research is multidisciplinary, incorporating perspectives in Methamphetamine, Drug and Opioid. The Stereochemistry study combines topics in areas such as Serotonin transporter, Structure–activity relationship, Chemical synthesis and Binding site.
Amy Hauck Newman spends much of her time researching Pharmacology, Dopamine, Dopamine receptor D3, Dopamine transporter and Receptor. Her research integrates issues of Antagonist, Partial agonist, Addiction and Opioid in her study of Pharmacology. Her work carried out in the field of Dopamine brings together such families of science as Biophysics, Self-administration and Reuptake.
The study incorporates disciplines such as Drug target, G protein and Functional selectivity in addition to Dopamine receptor D3. Her study in Dopamine transporter is interdisciplinary in nature, drawing from both Metabolic stability and Tropane. Her work deals with themes such as Chirality, Stereochemistry and In vivo, which intersect with Receptor.
Amy Hauck Newman mostly deals with Dopamine, Receptor, Pharmacology, Neuroscience and Dopamine receptor D3. Her studies deal with areas such as Self-administration and Monoamine neurotransmitter as well as Dopamine. In her study, which falls under the umbrella issue of Receptor, Morphine, 5-HT1A receptor, 5-HT receptor, Partial agonist and Heteromer is strongly linked to Dopaminergic.
Her research in Pharmacology intersects with topics in Addiction and Opioid. In her study, Heart rate, Blood pressure, Opioid use disorder and Extinction is inextricably linked to Antagonist, which falls within the broad field of Dopamine receptor D3. Her Dopamine transporter research includes themes of Microdialysis, Stimulant and Modafinil.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Structure of the human dopamine d3 receptor in complex with a d2/d3 selective antagonist.
Ellen Y. T. Chien;Wei Liu;Qiang Zhao;Vsevolod Katritch.
Genetic basis for species vulnerability in the Cheetah
Stephen J. O'Brien;M. E. Roelke;L. Marker;A. Newman.
The binding sites for cocaine and dopamine in the dopamine transporter overlap
Thijs Beuming;Julie Kniazeff;Marianne L Bergmann;Lei Shi.
Nature Neuroscience (2008)
Time-resolved FRET between GPCR ligands reveals oligomers in native tissues
Laura Albizu;Martin Cottet;Martin Cottet;Martin Cottet;Michaela Kralikova;Stoytcho Stoev.
Nature Chemical Biology (2010)
Current perspectives on selective dopamine D(3) receptor antagonists as pharmacotherapeutics for addictions and related disorders.
Christian A. Heidbreder;Amy H. Newman.
Annals of the New York Academy of Sciences (2010)
Cooperative transcription activation by Nurr1 and Pitx3 induces embryonic stem cell maturation to the midbrain dopamine neuron phenotype
Cecile Martinat;Jean-Jacques Bacci;Thomas Leete;Jongpil Kim.
Proceedings of the National Academy of Sciences of the United States of America (2006)
Tyr-95 and Ile-172 in Transmembrane Segments 1 and 3 of Human Serotonin Transporters Interact to Establish High Affinity Recognition of Antidepressants
L. Keith Henry;Julie R. Field;Erika M. Adkins;M. Laura Parnas.
Journal of Biological Chemistry (2006)
The novel dopamine D3 receptor antagonist NGB 2904 inhibits cocaine's rewarding effects and cocaine-induced reinstatement of drug-seeking behavior in rats.
Zheng-Xiong Xi;Amy Hauck Newman;Jeremy G Gilbert;Arlene C Pak.
Medication discovery for addiction: translating the dopamine D3 receptor hypothesis.
Amy Hauck Newman;Brandi L. Blaylock;Michael A. Nader;Jack Bergman.
Biochemical Pharmacology (2012)
Acute administration of SB-277011A, NGB 2904, or BP 897 inhibits cocaine cue-induced reinstatement of drug-seeking behavior in rats: role of dopamine D3 receptors.
Jeremy G. Gilbert;Amy Hauck Newman;Eliot L. Gardner;Charles R. Ashby.
Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking h-index is inferred from publications deemed to belong to the considered discipline.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: